3 ASX shares that could double over the next decade (or much sooner)

These shares could be positioned to deliver strong returns in the future. Let's find out why.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Finding ASX shares that can double in value is no easy task.

But history shows that companies with strong competitive advantages, large market opportunities, and scalable business models can deliver outsized returns over time.

In many cases, these businesses are still early in their growth journey, which gives them a long runway to expand.

Here are three ASX shares that could have the potential to double over the next decade, or even sooner if things go their way.

a man wearing casual clothes fans a selection of Australian banknotes over his chin with an excited, widemouthed expression on his face.

Image source: Getty Images

Life360 Inc. (ASX: 360)

The first ASX share that could deliver strong long-term returns is Life360.

It is a family safety and location platform provider that has built a large and highly engaged global user base. Its app provides services such as real-time location sharing, driving reports, and emergency assistance.

What makes Life360 particularly compelling is its monetisation opportunity. While almost 100 million users are already on the platform, only a portion currently pay for premium features. This creates significant upside as the company continues converting free users into paying subscribers.

In addition, Life360 is expanding into new services such as advertising and partnerships, which could further increase revenue per user. With strong growth in users and improving monetisation, the business appears well positioned to scale meaningfully over time.

Netwealth Group Ltd (ASX: NWL)

Another ASX share that could be capable of doubling is Netwealth.

It provides a wealth management platform used by financial advisers and investors. Its platform allows users to manage investments, superannuation, and portfolios in a streamlined and efficient way.

The company has been consistently gaining market share from traditional providers, driven by its modern technology and user-friendly interface.

Importantly, the platform model is highly scalable. As funds under administration grow, revenue increases without a corresponding rise in costs, supporting margin expansion over time.

With structural tailwinds from the shift towards independent advice and digital platforms, Netwealth could continue growing strongly over the next decade.

Pro Medicus Ltd (ASX: PME)

A third ASX share that could deliver outsized returns is Pro Medicus.

It provides imaging software to hospitals and healthcare providers, with its Visage platform offering best-in-class, high-performance diagnostic imaging capabilities.

The company has built a strong position in the United States, where it continues to win large contracts with leading healthcare institutions. These deals are often long-term and high value, providing excellent revenue visibility.

Furthermore, the company's business model is highly scalable. Once its software is deployed, additional usage comes at minimal incremental cost, which supports very high margins.

With a large addressable market and a proven ability to win new contracts, Pro Medicus appears well placed to continue growing. If it maintains its momentum, its shares could deliver significant returns for investors over the long term, especially after a sharp pullback in 2026.

Motley Fool contributor James Mickleboro has positions in Life360 and Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and Netwealth Group. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360 and Netwealth Group. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Growth Shares

2 under-the-radar ASX shares with bags of potential

It could be worth getting better acquainted with these shares.

Read more »

Happy man working on his laptop.
Growth Shares

Brokers rate these 3 top ASX shares as buys in April

Experts are optimistic about what these businesses can achieve.

Read more »

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »